Safety of atorvastatin in Asian patients within clinical trials. - Wikidata - awgldk - TriplyDB

Safety of atorvastatin in Asian patients within clinical trials.

Safety of atorvastatin in Asian patients within clinical trials.

http://www.wikidata.org/entity/Q37456623

about

Regional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction.Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo.

P2860

Q47900774-26254E47-DABC-4375-93B8-2A9C70541CC4 Q55039606-52703E6F-125E-4583-AB93-41F8B7F43DCA

P2860

Safety of atorvastatin in Asian patients within clinical trials.

http://www.wikidata.org/entity/Q37456623

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Safety of atorvastatin in Asian patients within clinical trials.

@en

Safety of atorvastatin in Asian patients within clinical trials.

@nl

type

label

Safety of atorvastatin in Asian patients within clinical trials.

@en

Safety of atorvastatin in Asian patients within clinical trials.

@nl

prefLabel

Safety of atorvastatin in Asian patients within clinical trials.

@en

Safety of atorvastatin in Asian patients within clinical trials.

@nl

P1433

Q37456623-0DEC75EE-2170-441E-9BF0-76366513F2C3

P1476

Q37456623-EBB7736E-5366-44D5-BAAD-D35E938D8037

P2093

Q37456623-66D2A4C5-33C9-4FAD-B6D3-BDD4AB0BC9E3

Q37456623-8645EA8D-9D6F-48B9-A378-B66CD6AEB3FA

Q37456623-91C32B7F-1319-4FAB-B64D-D4852356DC58

Q37456623-A70D980B-B3BF-4F3F-8CA1-9418077222C4

P2860

Q37456623-0BA97E9C-A089-45B2-9642-30175592CA4B

Q37456623-19B2A25B-C437-453B-8834-BEC39DBD5B4F

Q37456623-1B52E529-A906-44F5-B8B8-41CE29822FCE

Q37456623-231B62AD-A61C-4E02-A6F6-B210918A4C6A

Q37456623-302BCEB6-AFC4-4635-8CF8-BF6B7F5AE0B6

Q37456623-42ABD5D6-D0FF-4948-8459-9F9E1AB9CF70

Q37456623-4F84AC27-8276-4606-BB9A-B69A0BB7B887

Q37456623-4FC8580C-76ED-4707-9852-914DFF369778

Q37456623-5998314F-2764-44ED-89CB-1A3B794069B9

Q37456623-62EA3C06-458A-4B86-96BC-3D26D68AF8AE

P304

Q37456623-D312C47C-FAD2-44EC-8052-842460503577

P31

Q37456623-BD3A692A-8CC5-4AB5-81B9-DAC671C1EE6B

P356

Q37456623-9DEECC0C-9B02-4E51-9A80-36020F8576D9

P433

Q37456623-8B2FF0D5-7006-4562-812D-C2E0517DD5E4

P478

Q37456623-A6E21E7B-B3C1-4498-98BF-73EAB662DCEE

P50

Q37456623-6418BA1C-91CC-4044-A1E6-BE707117C05D

P577

Q37456623-73247D7B-FB89-4D0B-99F7-E4D2E739BB3D

P698

Q37456623-2D30EC70-DDC1-4476-9BFE-2482C67DBDFB

P932

Q37456623-F4BDE256-B80E-492B-9129-0FB7B7EB786C

P356

1755-5922.12214

P1433

Cardiovascular Therapeutics

P1476

Safety of atorvastatin in Asian patients within clinical trials

@en

P2093

Alice P S Kong

http://www.w3.org/2001/XMLSchema#string

Rachel Laskey

http://www.w3.org/2001/XMLSchema#string

Rana Fayyad

http://www.w3.org/2001/XMLSchema#string

Weihang Bao

http://www.w3.org/2001/XMLSchema#string

P2860

Use of atorvastatin in lipid disorders and cardiovascular disease in Chinese patients

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia.

Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.

P304

431-440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1755-5922.12214

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Juliana Chung-ngor Chan

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27520479

http://www.w3.org/2001/XMLSchema#string

P932

5129583

http://www.w3.org/2001/XMLSchema#string